Incyte

Incyte is a biopharmaceutical company founded by researchers, chemists and biologists in the United States. Incyte has retained a strong research culture, reflected in substantial R&D investment (+40% of sales) and drug discovery by its own researchers. Drawing on its in-depth knowledge and understanding of cellular oncogenic pathways and immune system function, Incyte continues to advance research in oncology, inflammation and autoimmunity. In Europe, where Incyte operates in 10 countries with a state-of-the-art plant in Switzerland, Incyte has obtained 4 marketing authorizations.